Product Information
PROCTOFOAM 1% FOAM is a brand product labeled by Viatris Specialty LLC, priced at $6.5614 per GM under NDC 00037682315. Its NADAC has been published 107 times since Sep 18, 2024.
Strength
150 mg/15g
Manufacturer
Viatris Specialty LLCNDC
00037682315
Classification
Brand
Dosage Form
AEROSOL, FOAM
Route
RECTAL
Effective Date
9/23/2026
Active Ingredients
PRAMOXINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M346On Market Since
8/18/2014
Price Statistics
The NADAC for PROCTOFOAM 1% FOAM has been published 107 times since Sep 18, 2024, and over the history we have for it it has risen 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.5614 per GM |
|---|---|
| All-time high | $7.1734 (Aug 12, 2026) |
| All-time low | $5.8764 (Sep 18, 2024) |
| 52-week high | $7.1734 |
| 52-week low | $6.0131 |
| Median price | $6.3254 |
| Average price | $6.3992 |
| Largest weekly change | +8.6% (Jun 17, 2026) |
| Weeks tracked | 107 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the pramoxine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viatris Specialty LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
pramoxine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROCTOFOAM 1% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for PROCTOFOAM 1% FOAM, manufactured by Viatris Specialty LLC, is $6.5614 per GM (NDC 00037682315), effective Sep 30, 2026.
How has the price of PROCTOFOAM 1% FOAM changed over time?
Over the history we have for it, the NADAC for PROCTOFOAM 1% FOAM has risen 11.7%. It has been tracked across 107 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for PROCTOFOAM 1% FOAM?
Since Sep 18, 2024, the NADAC for PROCTOFOAM 1% FOAM has ranged from a low of $5.8764 (Sep 18, 2024) to a high of $7.1734 (Aug 12, 2026), with a median of $6.3254 per GM.
Are there cheaper alternatives to PROCTOFOAM 1% FOAM?
No other NADAC-published product currently shares the active ingredient and strength of PROCTOFOAM 1% FOAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PROCTOFOAM 1% FOAM?
PROCTOFOAM 1% FOAM (NDC 00037682315) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.